Madhav Vasanthavada is CCO at ABEONA THERAPEUTICS INC. (ABEO). They have made 5 open-market trades across 1 company since 2026, most recently 2026-09-29.
CIK 0002106295
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ABEO | 285,721 | $1.3M |
Shares reported on the most recent Form 4, priced at the 2026-09-29 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ABEO | SELL | 2026-09-29 | 2026-09-29 | $5.16 | $25K | -3.5% | — | — |
| ABEO | SELL | 2026-07-09 | 2026-07-09 | $6.96 | $88K | -9.5% | +3.0% | -29.7% |
| ABEO | SELL | 2026-06-08 | 2026-06-09 | $5.36 | $52K | +5.1% | +30.4% | +7.0% |
| ABEO | SELL | 2026-05-11 | 2026-05-11 | $5.96 | $33K | -3.5% | -6.6% | +29.9% |
| ABEO | SELL | 2026-01-22 | 2026-01-26 | $5.29 | $67K | -4.7% | +3.1% | +3.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.